Surgical treatment of primary gastrointestinal stromal tumors (GISTs): Management and prognostic role of R1 resections

被引:19
作者
Pantuso, Gianni [1 ]
Macaione, Ina [1 ]
Taverna, Alessandra [1 ]
Guercio, Giuseppina [1 ]
Incorvaia, Lorena [1 ]
Di Piazza, Marianna [1 ]
Di Grado, Fulvia [1 ]
Cilluffo, Giovanna [2 ]
Badalamenti, Giuseppe [1 ]
Cipolla, Calogero [1 ]
机构
[1] Univ Palermo, Dept Surg Oncol & Oral Sci, Via Vespro 129, I-90127 Palermo, Italy
[2] CNR, Ist Ric & Innovaz Biomed IRIB, Palermo, Italy
关键词
GISTs; Surgery; Positive microscopic margins; Prognosis; CLINICAL PRESENTATION; IMATINIB; DIAGNOSIS; PATHOLOGY; ADJUVANT; SURGERY; MARGINS; AUDIT; KIT;
D O I
10.1016/j.amjsurg.2019.12.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Surgery represents the best treatment for primary gastrointestinal stromal tumors (GISTs). The aim of this study is to analyse outcomes of surgical management in order to evaluate the influence of microscopically R1 margins on survival and recurrence in patients affected by GISTs. Methods: The study reviewed retrospective data from 74 patients surgically treated for primary GISTs without metastasis at diagnosis. Clinical and pathological findings, surgical procedures, information about follow up and outcomes were analyzed. Results: Recurrence rate was low and no patients died in the R1 group during the follow up period. The difference in recurrence free survival for patients undergoing an R0 (n = 54) versus an R1 (n = 20) resections was not statistically significant (76% versus 85% at 3 years, logrank test p -value = 0,14; 63% versus 86% at 5 years, logrank test p -value = 0,48) Conclusions: Microscopically positive margin has no influence on overall and relapse -free survival in GIST patients. Thus, when R0 surgery implies major functional sequelae, it may be decided to accept possible R1 margins, especially for low risk tumors. (c) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:359 / 364
页数:6
相关论文
共 36 条
  • [21] Prognostic factors influencing surgical management and outcome of gastrointestinal stromal tumours
    Langer, C
    Gunawan, B
    Schüler, P
    Huber, W
    Füzesi, L
    Becker, H
    [J]. BRITISH JOURNAL OF SURGERY, 2003, 90 (03) : 332 - 339
  • [22] Lin SC, 2003, WORLD J GASTROENTERO, V9, P2809
  • [23] Microscopically Positive Margins for Primary Gastrointestinal Stromal Tumors: Analysis of Risk Factors and Tumor Recurrence
    McCarter, Martin D.
    Antonescu, Cristina R.
    Ballman, Karla V.
    Maki, Robert G.
    Pisters, Peter W. T.
    Demetri, George D.
    Blanke, Charles D.
    von Mehren, Margaret
    Brennan, Murray F.
    McCall, Linda
    Ota, David M.
    DeMatteo, Ronald P.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2012, 215 (01) : 53 - 59
  • [24] Miettinen Lasota J, 2003, POL J PATHOL, V54, P3
  • [25] Gastrointestinal stromal tumors of the jejunum and ileum - A clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up
    Miettinen, M
    Makhlouf, H
    Sobin, LH
    Lasota, J
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (04) : 477 - 489
  • [26] Gastrointestinal stromal tumors of the stomach - A clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up
    Miettinen, M
    Sobin, LH
    Lasota, J
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (01) : 52 - 68
  • [27] Gastrointestinal stromal tumors: Pathology and prognosis at different sites
    Miettinen, Markku
    Lasota, Jerzy
    [J]. SEMINARS IN DIAGNOSTIC PATHOLOGY, 2006, 23 (02) : 70 - 83
  • [28] Miettinen M, 2006, ARCH PATHOL LAB MED, V130, P1466
  • [29] Gastrointestinal Stromal Tumors
    Miettinen, Markku
    Lasota, Jerzy
    [J]. GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2013, 42 (02) : 399 - +
  • [30] Histopathology of Gastrointestinal Stromal Tumor
    Miettinen, Markku
    Lasota, Jerzy
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2011, 104 (08) : 865 - 873